CytoDyn Inc./ US23283M1018 /
7/6/2022 3:46:35 PM | Chg. -0.0009 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.3901USD | -0.23% | 65,939 Turnover: 25,750.1075 |
-Bid Size: - | -Ask Size: - | 0.3950 | 0.3868 |
GlobeNewswire
1/26
Proactive news headlines including Tesla, Gratomic, Ridgeline Minerals, Audacious, Universal Ibogain...
GlobeNewswire
1/10
Proactive news headlines including Starton Therapeutics, Safe-T Group, Genprex, Hawkmoon Resources, ...
GlobeNewswire
1/5
Proactive news headlines including Valeo Pharma, Plurilock Security, Magna Mining, BTU Metals and Ul...
GlobeNewswire
12/21/2021
Proactive news headlines including Benchmark Metals, Gratomic, Cypress Development, American Battery...
GlobeNewswire
12/13/2021
Proactive news headlines including Mountain Boy, CytoDyn, Tracesafe, Great Atlantic Resources, Fobi ...
GlobeNewswire
12/9/2021
Proactive news headlines including Great Bear Resources, Vendetta, Thunderbird Entertainment, Aladdi...
GlobeNewswire
12/8/2021
Proactive news headlines including Nerds on Site, Cypress Development, Sassy Resources, Goldshore Re...
GlobeNewswire
12/1/2021
Proactive news headlines including Ethereum, BioSig Technologies, Deep-South Resources, Victory Squa...
GlobeNewswire
11/24/2021
Proactive news headlines including Apple, Pathway Health, ImagineAR, Great Bear Resources, Arrow Exp...
GlobeNewswire
11/19/2021
Proactive news headlines including Alibaba, Fireweed Zinc, Sigma Lithium, Todos Medical and MedX
GlobeNewswire
11/16/2021
Proactive news headlines including Contakt World Technologies, CULT Food, Kontrol Technologies, Rio2...
GlobeNewswire
11/16/2021
CytoDyn Reminds Stockholders to Register 24 hours before November 24th Annual Meeting
GlobeNewswire
11/16/2021
CytoDyn Submits the First of Three Main Sections of HIV BLA to FDA Under Previously Authorized Rolli...
GlobeNewswire
11/8/2021
Proactive news headlines including Tesla, MGX Minerals, Bragg Gaming, Clean Air Metals, Harbor Custo...
GlobeNewswire
11/8/2021
CytoDyn Submits Breakthrough Therapy Designation Application to FDA for Leronlimab as a Treatment fo...
GlobeNewswire
11/3/2021
Proactive news headlines including Coinsilium, Altamira Gold, Kootenay Silver, Quaterra Resources, I...
GlobeNewswire
11/3/2021
CytoDyn Reports Preliminary Results from First Five Patients in Phase 2 NASH Open Label Leronlimab T...
GlobeNewswire
11/3/2021
CytoDyn Announces Cancer Update: 12-month Analysis of 28 mTNBC Patients Receiving Leronlimab Suggest...
GlobeNewswire
10/28/2021
Proactive news headlines including Greenrose Acquisition, Nextleaf Solutions, Playgon Games, Tartisa...
GlobeNewswire
10/28/2021
CytoDyn Announces FDA Accepts Revised Rolling Review Timeline for Resubmission of its BLA